ror,sponsor_name,sponsor_article,number_of_trials,10Y_indicator,10Ydrug_indicator,10Y_lastyear_indicator,10Y_lastyear_drug_indicator,10Y_indicator_france,10Ydrug_indicator_france,10Y_lastyear_indicator_france,10Y_lastyear_drug_indicator_france
01kv58h76,ANRS Maladies infectieuses Ã©mergentes,de l',102,49 %,72 %,10 %,17 %,51 %,76 %,32 %,53 %
